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Sutherlandia frutescens (L.) R.Br. is extensively used in South Africa to treat a broad range of ailments such as the common cold and cancers and,
recently, as adjunct therapy in HIV/AIDS. However, scientiﬁc studies focusing on the phytochemical proﬁle and variation within and between
populations of this ethnomedicinally important species are lacking. The amino acids GABA, L-canavanine, L-asparagine, and L-arginine and a glycan,
D-pinitol, have been proposed as being responsible for the pharmacological activity ascribed to S. frutescens. Aerial parts of S. frutescenswere collected
from several natural populations and cultivation sites. All 20 naturally occurring amino acids together with GABA, L-canavanine and D-pinitol were
quantiﬁed by LC-MS. Amino acids collectively constituted between 10% and 15% (w/w) of dried plant material. Proline, L-asparagine and
alanine were the most abundant amino acids identiﬁed and collectively represent approximately 60% of total amino acid content; however,
not all samples contained all the amino acids. The yields of the various compounds showed tremendous variation both within and between
populations. For example, L-canavanine (a non-protein amino acid) ranged from 0.14 to 13.58 mg/g. This is the ﬁrst report on the variation of
phytoconstituents claimed to contribute to the pharmacological properties of Cancer bush. This information could be of value to select
speciﬁc chemotypes for cultivation and for developing guidelines for quality control purposes.
© 2012 SAAB. Published by Elsevier B.V. All rights reserved.
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Sutherlandia frutescens (Leguminosae) (=Lessertia frutescens)
has an illustrious history of traditional use in southern Africa. This
species has been employed by various ethnic groups including the
Zulu, Khoi-San, Xhosa and Cape Dutch to treat a diversity of
ailments ranging from the minor cold to HIV and cancer, for which
it is used as adjunct therapy (Van Wyk and Albrecht, 2008).
Because of its versatility, S. frutescens has several vernacular
names that mostly refer to its ethnomedicinal importance. In
Setswana, it is called ‘petola’ which means ‘it changes’, implying
that the plant changes the course of many illnesses towards a
favourable outcome. The Northern Sesotho vernacular name
‘lerumo-lamadi’ means ‘the spear for the blood’ indicating that
Sutherlandia is a powerful blood-purifier and all-purpose tonic.⁎ Corresponding author. Tel.: +27 12 3826360; fax: +27 12 3826243.
E-mail address: viljoenam@tut.ac.za (A.M. Viljoen).
0254-6299/$ -see front matter © 2012 SAAB. Published by Elsevier B.V. All right
doi:10.1016/j.sajb.2012.06.009Sutherlandia frutescens is called ‘motlepelo’ in Sesotho, which
means ‘bringing back the heart’.
The limited literature available on the phytochemistry of
Sutherlandia has reported (in general) on the presence of free
amino acids, non-protein amino acids, pinitol, flavonoids and
triterpenoid saponins (Van Wyk and Albrecht, 2008). Studies
have suggested that the biological activity may be ascribed to
γ-aminobutyric acid (GABA), L-canavanine, L-arginine,
L-asparagine and D-pinitol (Tai et al., 2004). These com-
pounds have been directly linked to various pharmacological
activities associated with S. frutescens. L-canavanine has well-
documented anticancer and antiviral properties, including effects
on Haemophilus influenza and retroviruses such as HIV
(Swaffar, 1995; Bence et al., 2003). Claims have been made
that the administration of S. frutescens tablets to HIV positive
patients improves the mood, appetite, viral load and CD4 counts
(Morris, 2001). GABA, formed during the decarboxylation of
glutamic acid, is an inhibitory neurotransmitter found in thes reserved.
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structurally analogous to L-arginine, is a hydroxylamine
derivative and belongs to the group of non-protein amino
acids (Fig. 1).
Another prominent component of S. frutescens is L-arginine, an
antagonist of L-canavanine that attenuates the anti-proliferative
activity of L-canavanine. L-arginine stimulates the release of
insulin, which in turn promotes the synthesis of muscle protein
while L-asparagine causes postprandial glucagon secretion.
L-asparagine is a non-essential, neutral, hydrophilic amino acid. It
is the acid amide of asparaginic acid and is uncharged at
physiological pH. Glucagon activates gluconeogenesis from
amino acids in the liver, so an efficient reduction of plasma
amino acid concentration occurs after meals (Mills et al., 2005).
D-pinitol is a glycanwhich is present inmany leguminous plants. In
the body, it is converted into D-chiro-inositol (Prevoo et al., 2008),
which is involved as a second messenger in a number of different
metabolic processes, including blood sugar metabolism and thus
has an insulin-like effect (Larner, 2002).
Despite the plethora of traditional uses associated with
Sutherlandia and the several consumer products which have
been commercialized, the chemistry and phytochemical variation
remains largely unexplored. Assessing the phytochemical content
and chemotypic variation of a species is basic information of
paramount importance that will influence the safety, efficacy and
quality of any herbal medicine. The purpose of this paper is to
report the chemotypic variation within and between natural
populations and commercial collections which would provide
critical information for developing quality control protocols
based on the quantitative assessment of the bioactive amino acids
and D-pinitol.
2. Materials and methods
2.1. Collection of plant materials
Sutherlandia frutescens samples were collected from different
natural populations (n=87) to investigate geographical variation
and from a commercial plantation (n=60) (Table 1). These were
dried in a Scientific series 2000 oven at 80 °C overnight, then
finely ground using a a Retsch® MM 400 ball mill (Monitoring
and Control (Pty) Ltd., Haan, Germany) at frequency 30 Hz forHO NH2
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Fig. 1. Selected chemical structures of bioactive constituents of Sutherlandia frutes
E: L-arginine.90 s, and thereafter passed through 500 μm mesh (Endcotts
Filters LTD, London).
2.2. Selection of samples for amino acid and pinitol quantification
Preliminary qualitative analysis of all samples was done
using near- and mid infrared spectroscopy. Chemometric
analysis was performed using SIMCA-P+® version 12.0
software (Umetrics AB., Malmo, Sweden). An unsupervised
method, principal component analysis (PCA) was employed in
order to provide an overview of the clustering patterns of the
samples and thus enable selection of representative samples.
Subsequently, 51 representative samples were selected for
amino acid and D-pinitol analysis which would reflect
within and between population variation and also allow for
a comparison between natural populations and commercial
material.
2.3. Quantification of amino acids
The pulverised and sieved material was investigated using
the amino acid derivatisation kit (EZ:Faast free amino acid
analysis kit, Phenomenex, Torrance, CA, USA). Derivatisation
methods were applied to increase detector response and to
improve separation and the retention on reverse phase columns
of these compounds. Approximately 100 mg of dried leaf
powder was weighed out and extracted with 2 ml of 50%
acetonitrile and 0.1% formic acid solvent mixture. The samples
were vortexed and sonicated for 1 h, extracted overnight and
sonicated for 1 h the following day. The extracted samples
were subsequently centrifuged (252×g) for 5 min and the
supernatant filtered through a 0.22 μm filter; 100 μl of the
filtrate was subjected to EZ:Faast analysis for amino acid
analysis. Labeled homo-L-arginine and methionine-D3 were
included as internal standards and are part of the EZ:Faast kit.
The supplied EZ:Faast standard that contains a cocktail of all
the amino acids detected with the method was diluted to 20, 40,
100, 120 and 200 nmol/ml. A Waters API Quattro Micro triple
quadrupole mass spectrometer (MS), connected to an Alliance
High Performance liquid chromatograph (HPLC) (all from
Waters, Milford MA, USA) was used. A binary HPLC gradient
was used with 10 mM ammonium formate in water (solvent A)H
H2N NH NH2
OH
NH O
OH
OH
OCH3HO OHHO
C
E
cens. A: γ‐aminobutyric acid; B: L-asparagine; C: D-pinitol; D: L-canavanine;
Table 1
Locality data and codes for Sutherlandia frutescens samples.
Sample name Plant part Locality
SF 1 Stems Kruishof Farm (Wellington)
SF 2 Leaves Kruishof Farm
SF 3 Blossoms Kruishof Farm
SF 4 Sticks Kruishof Farm
SF 5 Seeds Kruishof Farm
SF 6 Leaves Hofmeyer
SF 7 Leaves Steynsburg
SF 8 Leaves Jamestown
SF 9 Leaves King Williams Town
SF 10 Leaves Vanrhynsdorp
SF 11 Leaves Elliot
SF 12 Leaves Molteno
SF 13 Leaves Ladismith (Barrydale road)
SF 14 Leaves Jordaan
SF 15 Leaves Zastron
SF 16 Leaves Klawer
SF 17–66 ⁎ Leaves Kruishof Farm (Wellington)
SF 67–69 ⁎⁎ Leaves Gansbaai (A)
SF 70–72 ⁎⁎ Leaves Lydenburg, road to Buffelskloof Farm
SF 73–75 Leaves Gansbaai (B)
SF 76–78 Leaves Gansbaai (C)
SF 79–81 Leaves Gansbaai (D)
SF 82–84 Leaves Darling
SF 85–87 Leaves Gansbaai (E)
SF 88–90 Leaves Melkbosstrand
SF 91–93 Leaves Gansbaai (F)
SF 94 Pods Kruishof Farm (Wellington)
SF 95 Leaves Matjiesfontein (near Grootdam Farm)
SF 96 Leaves Oudtshoorn
SF 97 Leaves Barrydale
SF 98–100 Leaves Between Matjiesfontein and Sutherland
SF 101–102 Leaves Somerset West (Vergelegen road)
SF 103–105 Leaves Between Dysseldorp-Harold (A)
SF 106–108 Leaves Between Dysseldorp-Harold (B)
SF 109–111 ⁎⁎ Leaves Heimersrivier
SF 112–114 ⁎⁎ Leaves Mount Hope
SF 115–117 ⁎⁎ Leaves Calitzdorp (next to Gamka River)
SF 118 Leaves Oudtshoorn near Agricultural Experimental Farm
SF 119–121 Leaves Laingsburg
SF 122–124 Leaves Oudtshoorn (south of Gamkaberg)
SF 125–127 Leaves Oudtshoorn (near Slangrivier)
SF 128 ⁎⁎ Leaves Willowmore
SF129–131 Leaves Kruishof Farm (Wellington)
SF 132 ⁎⁎ Leaves Riversdale
SF 133 ⁎⁎ Leaves Between Oudtshoorn and De Rust
SF 134 ⁎⁎ Leaves Uniondale
SF 135 ⁎⁎ Leaves Ceres-Calvinia road
SF 136 ⁎⁎ Leaves Barrydale
SF 137–141 ⁎⁎ Leaves Calitzdorp (Badshoogte)
SF 142–144 ⁎⁎ Leaves Harold (Paardepoort)
SF 145–147 Leaves Near Prins Albert
⁎ 24 of these samples selected for amino acid and pinitol quantification.
⁎⁎ Samples selected for amino acid and pinitol quantification.
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gradient started at 32% solvent A to 17% solvent A over
13 min, followed by a 5 min equilibration to initial conditions
to yield a total run time of 17 min. The EZ:Faast amino acid
analysis column was employed at a flow rate of 0.28 ml/min
and a column oven temperature of 40 °C. The injection volume
was 10 μl. Electrospray ionisation in the positive mode wasused, a capillary voltage of 3.5 kV; cone voltage of 18 V;
source temperature of 100 °C and desolvation temperature of
350 °C was used. Nitrogen was used as desolvation gas at a
setting of 350 L/h and also as cone gas at 50 L/h.
The MS method consisted of 3 MRM (multiple reaction
monitoring) functions, containing 10, 9 and 5 mass pairs
respectively. These MRM settings were setup according to the
supplied MRM transitions in the EZ:Faast protocol.2.4. Quantification of GABA and L-canavanine
Approximately 100 mg of dried leaf powder was weighed
out and extracted with 2 ml of 50% acetonitrile and 0.1%
formic acid followed by vortexing and sonication. Each sample
was vortexed for 5–10 s and centrifuged at 252×g for 5 min
using a Hermle® bench centrifuge. A 50 μl aliquot of the
supernatant was placed into a glass hydrolysis tube, dried under
vacuum using a rotary vane vacuum pump (RZ2, Lasec, Cape
Town, SA) and a glass vacuum manifold with a liquid nitrogen
trap (to prevent the solvent vapour to reach the pump) for 1 h.
Further processing of the samples included the addition of
20 μl methanol:water:triethylamine (2:2:1) to adjust the pH to
neutral, after which the samples were dried for 1 h using the
same system as above. Samples were derivatised by addition of
20 μl derivatising solution (methanol:water:triethylamine:
phenylisothiocyanate (PITC) 7:1:1:1). The mixture was incu-
bated at room temperature for 10 min and then dried under
vacuum for 90 min or until complete dryness, but for no longer
than 3 h. The derivatised dried sample was then dissolved in
200 μl of Picotag® sample diluent (Waters, Milford, MA,
USA). A Waters API Quattro Micro triple quadrupole mass
spectrometer connected to a Waters Alliance 2695 HPLC,
equipped with a photodiode array detector (PDA) (Waters,
Milford MA, USA), was used. The PDA detector was set to
record data between 230 and 450 nm. An XBridge C18,
3.5 μm, 2.1×50 mm column (Waters, Milford MA, USA) was
used, with a gradient starting with 96% solvent A (0.1% formic
acid), holding time of 1 min followed by a 7 min linear
gradient to 60% solvent B (acetonitrile) and returning to initial
conditions over 7 min. The injection volume was 10 μl, the
column oven temperature was 35 °C and the flow rate was
0.40 ml/min. The mass spectrometry was performed in the
positive ionisation mode using an electrospray source and the
conditions were as follows: capillary voltage: 3.5 kV; cone
voltage: 15 V; source temperature: 100 °C; desolvation tem-
perature: 380 °C; desolvation gas flow rate: 400 L/h and cone
gas flow rate: 50 L/h. The MRM transitions monitored was
312.2N237, at a retention time of 4.01 min for canavanine and
239N86, at a retention time of 6.81 min for GABA. The
collision energy was set at 15 V for both MRMs (Colling et al.,
2010). Linear 5 point calibration curves were constructed using
L-canavanine (Sigma C1625) of which 8.563 mg was weighed
out and diluted with methanol (2.68–214 μg/ml) and GABA
(kindly supplied by the Department of Biochemistry, Stellen-
bosch University) of which 14.50 mg was weighed out and
diluted with methanol (4.53–362.50 μg/ml).
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Dried plant powder (100 mg) was extracted with 0.1%
aqueous formic acid (5 ml) in an ultrasonic bath for 1 h and
then filtered. After filtration, 5 μl of the sample was injected
and analysed by LC-MS using Waters API Ultima Quadrupole
Time-of-Flight mass spectrometer (QTOF) connected to a
Waters Acquity Ultra performance liquid chromatograph. The
analysis was performed in the negative ionisation mode using
an electrospray source. The mass spectrometry conditions were
set as follows: capillary voltage: 3.5 kV; cone voltage: 35 V;
source temperature: 100 °C; desolvation temperature: 380 °C;
desolvation gas flow rate: 350 L/h and cone gas flow rate:
50 L/h. A Phenomenex Luna C5, 2.1×150 mm, 5 μm column
was employed at a flow rate of 0.18 ml/min. Mobile phase A
consisted of 750 mg/l octyl ammonium and solvent B consisted
of acetonitrile. The octyl ammonium acted as ion-pair reagent
to facilitate the retention of the very polar D-pinitol on the
reversed phase system. The gradient consisted of a initial 4 min
hold at 100% solvent A, followed by a linear gradient to 60%
solvent B to 14 min and equilibration to initial conditions to a
total run time of 20 min. The D-pinitol eluted just after the
column void at 2.6 min. The pinitol was quantified from the
extracted mass chromatogram of m/z 193 (Molecular Weight of
D-pinitol is 194). D-pinitol dilutions of 0.4–400 μg/ml were
used to construct a calibration curve.2.6. Data analysis
Chemometric data analysis of the amino acid data was
performed using SIMCA-P+12.0 software (Umetrics AB,0%
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Fig. 2. Phytochemical variation of biologically active amino acids; L-arginine,
Sutherlandia frutescens.Malmo, Sweden); all data was log-transformed for analysis.
Principal component analysis (PCA) was performed with the
aim of observing the clustering patterns using an unsupervised
method. Hierarchical cluster analysis was performed through
construction of a dendrogram. A PCA-score plot was used to
evaluate grouping and identify trends within the clusters. For
the chemometric analysis an average value was used for the 24
samples collected from Kruishof farm as they all represent a
single clone.3. Results and discussion
Fig. 2 shows the variation of biologically active amino acids
within selected populations of S. frutescens. Proline, L-asparagine
and alanine were the most abundant amino acids identified and
collectively represent approximately 60% of total amino acid
content. Table 2 summarizes the variation of amino acids for all
samples of S. frutescens. L-canavanine was the most variable
amino acid, ranging between 0.14 and 13.58 mg/g. The highest
yield detected for GABAwas 1.32 mg/g and D-pinitol was present
in low amounts, ranging from 0.02 to 0.73 μg/mg. However, not
all amino acids were present in all the samples analysed.
Phytochemical variation was previously investigated for a
single plant specimen to assess the distribution of the biologically
active constituents in the various plant organs (Mncwangi, 2009).
Stems contained high levels of L-arginine (2.60 mg/g) with
minimal levels of L-asparagine (0.50 mg/g). The L-asparagine
level in the young sticks was higher than in the stems (2.10 mg/g)
with lower levels of L-arginine (1.36 mg/g). Flowers contained
more L-asparagine (10.30 mg/g) than the other plant parts, and a
significant amount of L-arginine (1.80 mg/g). Mature seeds andF111 SF112 SF113 SF114 SF115 SF116 SF117
GABA
L-Canavanine
L-Asparagine
L-Arginine
ier Mount Hope Calitzdorp
d localities
L-asparagine, L-canavanine and GABA within and between populations of
Table 2
Summary of amino acid (mg/g) and D-pinitol (μg/mg) content in Sutherlandia frutescens from natural populations.
SF67 SF68 SF69 SF70 SF71 SF72 SF109 SF110 SF111 SF112 SF113 SF114 SF115 SF116 SF117
Locality GB GB GB LB LB LB HR HR HR MH MH MH CD CD CD
Alanine 0.47 0.45 0.5 0.85 1.35 0.82 2.17 1.14 3.02 2.64 1.19 0.95 0.75 0.67 0.41
L-Arginine 0.66 0.84 0.93 1.57 1.59 0.00 2.95 1.7 2.89 1.92 1.85 0.59 0.47 0.92 0.41
L-Asparagine 2.40 2.40 3.21 1.16 1.75 3.37 16.21 8.38 23.21 3.17 1.80 0.39 4.59 2.96 2.28
Aspartic acid 1.43 1.04 1.18 1.63 1.66 1.21 2.60 1.14 2.35 3.49 4.27 1.94 1.54 2.55 1.41
L-Canavanine 4.46 2.48 4.15 10.36 13.58 3.05 7.24 4.54 10.02 8.02 5.01 1.65 2.19 0.14 1.45
Cysteine 0.57 0.91 0.78 0.89 0.95 0.98 0.65 0.41 1.13 1.01 1.01 0.49 1.17 1.50 1.09
GABA 0.52 0.48 0.5 0.81 0.99 0.86 0.00 0.00 0.00 0.88 0.83 0.53 1.32 0.81 1.04
Glutamic acid 0.10 0.07 0.06 0.22 0.29 0.16 1.19 0.48 2.06 0.69 0.39 0.25 0.3 0.74 0.22
Glycine 0.16 0.14 0.16 0.18 0.26 0.14 0.11 0.07 0.15 0.22 0.09 0.08 0.18 0.17 0.11
Histidine 0.39 0.48 0.57 0.26 0.42 0.85 1.01 0.59 1.78 0.53 0.19 0.17 0.46 0.69 0.36
Isoleucine 0.10 0.12 0.10 0.56 1.01 0.45 1.35 0.21 0.72 0.83 0.66 0.27 0.54 0.42 0.47
Leucine 0.04 0.04 0.03 0.67 0.91 0.15 1.24 0.37 1.21 0.78 0.68 0.47 0.35 0.24 0.32
Lysine 0.10 0.14 0.12 0.45 0.28 0.07 0.55 0.30 1.29 0.44 0.61 0.57 0.11 0.18 0.25
Methionine 0.01 0.02 0.02 0.00 0.01 0.03 0.03 0.01 0.26 0.05 0.00 0.00 0.02 0.00 0.00
Phenylalanine 1.53 1.73 1.8 0.65 0.92 1.23 2.65 0.69 1.88 1.16 1.12 0.68 1.44 2.07 1.24
Proline 4.37 7.07 5.04 3.51 5.22 5.74 1.39 0.97 3.85 1.47 1.1 0.53 8.09 6.40 4.08
Serine 0.40 0.67 0.58 0.94 0.76 0.79 0.99 0.67 2.23 0.44 0.62 0.27 1.44 1.80 1.38
Threonine 0.47 0.81 0.68 0.79 0.85 0.88 0.55 0.31 1.03 0.91 0.91 0.39 1.07 1.40 0.99
Tryptophan 0.82 0.89 0.99 0.52 0.71 1.18 1.3 0.74 2.21 0.85 0.53 0.4 1.35 1.52 0.83
Tyrosine 0.09 0.11 0.14 0.57 0.78 0.15 1.23 0.22 0.78 0.71 0.87 0.52 0.34 0.22 0.46
Valine 0.62 0.83 0.76 0.59 1.23 1.65 2.32 0.72 2.00 1.49 0.69 0.33 1.37 1.39 0.86
D-Pinitol
Locality
Alanine
L-Arginine
L-Asparagine
Aspartic acid
L-Canavanine
Cysteine
GABA
Glutamic acid
Glycine
Histidine
Isoleucine
Leucine
Lysine
Methionine
Phenylalanine
Proline
Serine
Threonine
Tryptophan
Tyrosine
Valine
D-Pinitol
0.57 0.71 0.73 0.68 0.06 0.08 0.07 0.08 0.08 0.08 0.08 0.09 0.07 0.08 0.08
SF128 SF132 SF133 SF134 SF135 SF136 SF137 SF138 SF139 SF142 SF143 SF144 KH
WM RD DR UD Ce BD CD CD CD Hr Hr Hr KH Avg Min Max
0.26 0.49 0.49 0.37 1.21 1.67 0.68 0.48 0.79 0.79 0.54 0.48 1.51 0.97 0.26 3.02
0.87 1.20 1.09 1.30 2.05 3.23 1.47 1.53 1.96 1.96 0.77 0.95 0.56 1.37 0.00 3.23
5.24 8.74 8.3 6.99 10.4 5.40 3.95 3.59 5.38 5.38 5.68 6.52 0.96 5.49 0.39 23.21
0.77 2.52 1.57 2.73 3.23 1.36 1.07 0.62 0.99 0.99 0.54 0.66 0.31 1.67 0.31 4.27
0.84 1.39 1.29 3.88 3.70 8.18 13.58 3.18 5.53 3.48 5.28 1.73 5.58 4.49 0.14 13.58
0.32 0.34 0.43 0.37 0.60 0.72 0.62 0.44 0.87 0.87 0.80 0.91 0.61 0.77 0.32 1.50
0.00 0.72 0.60 0.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.43 0.00 1.32
0.46 0.86 0.67 0.73 0.75 0.71 0.600 0.51 1.19 1.19 0.39 0.79 0.51 0.59 0.10 2.06
0.06 0.15 0.14 0.11 0.27 0.14 0.18 0.12 0.21 0.21 0.14 0.11 0.93 0.18 0.06 0.93
0.02 0.01 0.13 0.13 0.02 0.01 0.04 0.01 0.07 0.07 0.05 0.22 1.08 0.38 0.01 1.78
0.17 0.24 0.24 0.23 0.55 0.82 0.55 0.34 0.78 0.78 0.48 0.46 0.63 0.50 0.10 1.35
0.22 0.35 0.50 0.3 0.51 0.87 0.94 0.63 1.16 1.16 0.68 0.61 0.89 0.58 0.03 1.24
0.11 0.25 0.36 0.18 0.25 0.39 0.56 0.42 0.78 0.78 0.34 0.36 2.05 0.44 0.07 2.05
0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.29 0.02 0.00 0.29
0.53 0.90 0.83 1.01 2.24 0.88 0.95 0.69 1.19 1.19 1.23 1.67 0.03 1.22 0.03 2.65
0.53 0.5 0.86 0.32 6.16 2.18 2.93 2.03 3.19 3.19 2.68 2.27 0.45 3.08 0.32 8.09
0.22 0.39 0.39 0.34 0.69 0.28 0.62 0.42 0.87 0.87 0.67 0.73 0.53 0.75 0.4 2.23
0.22 0.24 0.33 0.27 0.5 0.62 0.52 0.34 0.77 0.77 0.70 0.81 0.51 0.67 0.22 1.40
0.12 0.21 0.21 0.42 0.54 0.11 0.28 0.09 0.32 0.32 0.34 0.55 1.49 0.71 0.82 2.21
0.11 0.17 0.20 0.16 0.38 0.57 0.61 0.43 0.87 0.87 0.54 0.60 0.01 0.45 0.09 1.23
0.41 0.64 0.56 0.55 1.55 0.83 0.89 0.63 1.12 1.12 1.04 1.08 0.59 1.00 0.33 2.32
0.02 0.04 0.04 0.07 0.08 0.08 0.08 0.09 0.11 0.11 0.11 0.04 1.32 0.15 0.02 0.73
Localities: GB: Gansbaai (A); LB: Lydenburg; HR: Heimersrivier; MH: Mount Hope; CD: Calitzdorp (Badshoogte) Willowmore; RD: Riversdale; DR: De Rust;
UD: Uniondale; BD: Barrydale; Hr: Harold (Paardepoort); KH: Kruishof Farm (Wellington).
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seeds have high glutamic acid levels, whereas young seeds have
high L-asparagine and almost equal amounts of proline and
L-arginine 1.10 and 1.30 mg/g, respectively. Seeds of S.
frutescens have been found to contain higher levels of
L-canavanine compared to the other plant parts (Tai et al., 2004).
Table 3 shows the minimum, maximum and standard deviation of
the various amino acids and pinitol in the propagated clone from
Kruishof farm. L-Arginine, L-asparagine, L-canavanine andGABA, standard deviation values were 1.47, 2.12, 4.50 and
0.97 mg/g, respectively. This variability necessitates the need to
identify standardised clones, which produce sufficient yields of
the biologically active constituents.
Hierarchical cluster analysis of the data presented in Table 2
produced four distinct clusters: A, B, C and D (Fig. 3).
Chemotype A consisted of only two samples, SF109 and SF111
both had a high level of L-asparagine, 16.21 and 23.21 mg/g,
respectively. Chemotype B was comprised of samples from
Table 3
Summary of amino acid (mg/g) and D-pinitol (μg/mg) content in Sutherlandia
frutescens from Kruishof farm (Wellington) (n=24).
Avg Min Max STDEV
Alanine 1.05 0.24 3.65 0.84
L-Arginine 1.78 0.32 6.67 1.47
L-Asparagine 4.63 0 8.91 2.12
Aspartic acid 1.64 0.24 4.80 1.13
L-Canavanine 5.57 0.84 16.08 4.50
Cysteine 0.02 0 0.05 0.02
GABA 1.42 0.24 3.48 0.97
Glutamic acid 0.68 0.07 2.32 0.54
Glutamine 0.11 0.00 0.74 0.21
Glycine 0.13 0.03 0.47 0.11
Histidine 0.62 0.02 1.56 0.39
Isoleucine 0.37 0.09 0.93 0.25
Leucine 0.36 0.07 1.15 0.30
Lysine 0.24 0.03 0.68 0.18
Methionine 0.01 0.00 0.04 0.01
Phenylalanine 1.32 0.25 2.69 0.65
Proline 4.27 0.53 10.03 2.58
Serine 0.90 0.18 3.05 0.73
Threonine 0.51 0.11 1.83 0.41
Tryptophan 1.04 0.12 2.21 0.59
Tyrosine 0.40 0.11 0.83 0.22
Valine 1.19 0.34 2.88 0.65
D-Pinitol 1.32 0.25 2.69 0.65
51N.P. Mncwangi, A.M. Viljoen / South African Journal of Botany 82 (2012) 46–52Gansbaai, Calitzdorp and Lydenburg. The specimens from
Gansbaai clustered together depicting intrapopulation similari-
ties. However, this was in contrast to the Lydenburg population
where one specimen was included in cluster B and the two other
samples collected in the same population are nested in cluster C.
In cluster C, the maximum values for L-arginine, L-asparagine,
L-canavanine and GABA were 0.93, 4.59, 4.46 and 1.04 mg/g
respectively. Cluster D unites the samples with high yields of
L-canavanine and L-asparagine. Although GABA is proposed to
have biological activity, it did not contribute to cluster definition.D
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Fig. 3. Dendrogram produced by hierarchical clustering ofThe chemotypes observed were also not defined by geographical
location. Although this analysis provides a first attempt in
defining chemotypic variation in Sutherlandia frutescens the
dendrogrammust be interpreted with caution as the topology will
clearly change as more samples are introduced.
Amino acid profiles of samples from the same population
are variable within and between populations; however similar-
ities were observed in the Gansbaai population where all three
samples were united in the same cluster. There is variation
within populations, in the Heimersrivier population, two
samples clustered in chemotype A characterized by higher
proline levels, whereas the other sample was in chemotype D
which contains more L-canavanine. The same is observed for
the Calitzdorp population where two samples are placed in
chemotype B based on asparagine and L-canavanine and the
other sample from the same population is placed in cluster C
which is denoted by high yields of asparagine. This clearly
demonstrates that plants within the same population are
phytochemically variable, thus necessitating the establishment
of standardised clones and developing quality control param-
eters for raw materials used in product development.
Knowledge on the phytochemical variation is one of the basic
requirements to develop realistic quality control protocols. For
many years the quality control parameter for Hoodia gordonii
raw material was a requirement of 0.30% of P57, a steroidal
glycoside perceived to be the active constituent. Vermaak (2011)
analysed 145 samples collected from natural populations and also
from cultivation sites; however, only 4% of the 145 samples met
the required standard. Plants comprise of a wide spectrum of
metabolites (as many as 200 000 different compounds), although
not every metabolite occurs in every species (Fiehn et al., 2000).
Plant age, seasonal and geographical variation all contribute
towards variation in the phytochemistry and thus biological
activity of plants (Buwa and Van Staden, 2007; Shale et al., 2005;
Taylor and Van Staden, 2001). Biologically active compounds
occur in different amounts even in different organs of the same
plant (Lewinsohn and Gijzen, 2009). The safety and efficacy ofD
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52 N.P. Mncwangi, A.M. Viljoen / South African Journal of Botany 82 (2012) 46–52herbal medicines are closely correlated with the quality and
source of raw materials used during production (Calixto, 2000).
It is evident that the biologically active molecules of this
species are variable, within and between populations and even
within the same plant. This necessitates the implementation of
standardised methods, from harvesting protocols, where age,
season and geographical and environment are factors influenc-
ing the quantity of biologically active constituents. During
production of material for consumption, methods should be
designed in such a way that degradation of amino acids is
prevented; GABA and methionine are two amino acids which
are highly prone to degradation through hydrolysis. Further-
more, basic studies which will determine the effective
concentration (EC50) and lethal dose (LD50) are required. This
will enable the development of protocols which promote the
production of safe and efficacious phytomedicines.
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